Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rebecca Lynn Gillani, M.D.,Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K08NS107591 (GILLANI, REBECCA LYNN) Jul 15, 2018 - Jun 30, 2023
    Inflammation mediated evolving changes in synapse structural integrity and dynamics in vivo in a mouse model of multiple sclerosis
    Role: Principal Investigator
  2. F30NS060560 (GILLANI, REBECCA LYNN) Jun 22, 2007 - Jun 21, 2011
    Cognitive Recovery and Neuronal Plasticity after Stroke in the Aged
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Balcioglu A, Gillani R, Doron M, Burnell K, Ku T, Erisir A, Chung K, Segev I, Nedivi E. Mapping thalamic innervation to individual L2/3 pyramidal neurons and modeling their 'readout' of visual input. Nat Neurosci. 2023 Mar; 26(3):470-480. PMID: 36732641.
    Citations:    Fields:    Translation:AnimalsCells
  2. Manzano GS, Rice DR, Klawiter EC, Matiello M, Gillani RL, Tauhid SS, Bakshi R, Mateen FJ. Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study. Mult Scler. 2022 06; 28(7):1146-1150. PMID: 35475382.
    Citations: 1     Fields:    Translation:HumansCells
  3. Rice DR, Kaplan TB, Hotan GC, Vogel AC, Matiello M, Gillani RL, Hutto SK, Ham AS, Klawiter EC, George IC, Galetta K, Mateen FJ. Electronic pill bottles to monitor and promote medication adherence for people with multiple sclerosis: A randomized, virtual clinical trial. J Neurol Sci. 2021 09 15; 428:117612. PMID: 34392138.
    Citations: 1     Fields:    Translation:Humans
  4. Gillani RL, Podraza KM, Luthra N, Origitano TC, Schneck MJ. Factors Influencing the Management of Unruptured Intracranial Aneurysms. Cureus. 2016 May 04; 8(5):e601. PMID: 27335713; PMCID: PMC4895076.
    Citations: 3     
  5. Gillani RL, Tsai SY, Wallace DG, O'Brien TE, Arhebamen E, Tole M, Schwab ME, Kartje GL. Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy. Behav Brain Res. 2010 Apr 02; 208(2):415-24. PMID: 20035795.
    Citations: 25     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gillani's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (34)
Co-Authors (9)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.